speb/financial-data huggingface dataset:
TARS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -81000.00
TARS balance_sheet (quarterly, 2025-03-31) — Other Payable: 3916000.00
TARS balance_sheet (quarterly, 2025-03-31) — Other Properties: 1817000.00
TARS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 1727000.00
TARS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 232129000.00
TARS balance_sheet (quarterly, 2025-03-31) — Payables: 32299000.00
TARS balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 85924000.00
TARS balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
TARS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 5999000.00
TARS income_statement (quarterly, 2025-03-31) — Pretax Income: -25120000.00
TARS cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 1437000.00
TARS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
TARS cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -125570000.00
TARS cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -590000.00
TARS balance_sheet (quarterly, 2025-03-31) — Receivables: 64153000.00
TARS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 5211000.00
TARS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 460000.00
TARS income_statement (quarterly, 2025-03-31) — Research And Development: 14409000.00
TARS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -385330000.00
TARS cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 91218000.00
TARS income_statement (quarterly, 2025-03-31) — Selling General And Administration: 84995000.00
TARS balance_sheet (quarterly, 2025-03-31) — Share Issued: 41995537.00
TARS cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 6930000.00
TARS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 342458000.00
TARS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 334372000.00
TARS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
TARS income_statement (quarterly, 2025-03-31) — Tax Provision: 0.00
TARS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
TARS balance_sheet (quarterly, 2025-03-31) — Total Assets: 500750000.00
TARS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 414442000.00
TARS balance_sheet (quarterly, 2025-03-31) — Total Debt: 72368000.00
TARS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 342458000.00
TARS income_statement (quarterly, 2025-03-31) — Total Expenses: 104615000.00
TARS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 158292000.00
TARS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 19977000.00
TARS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 71984000.00
TARS income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -26280000.00
TARS income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: 139000.00
TARS cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: 0.00
TARS balance_sheet (quarterly, 2025-03-31) — Work In Process: 764000.00
TARS balance_sheet (quarterly, 2025-03-31) — Working Capital: 394465000.00
TARS income_statement (quarterly, 2025-06-30) — +Operating Expense: 118607000.00
TARS income_statement (quarterly, 2025-06-30) — +Total Revenue: 102660000.00
TARS balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 28075000.00
TARS balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 58334000.00
TARS balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -2409000.00
TARS balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 738237000.00
TARS cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 240000.00
TARS cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 240000.00
TARS cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: -1709000.00
TARS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 42360452.00
TARS income_statement (quarterly, 2025-06-30) — Basic EPS: -0.48
TARS cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 178350000.00
TARS cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -1001000.00
TARS balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 317000.00
TARS balance_sheet (quarterly, 2025-06-30) — Capital Stock: 6000.00
TARS balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 96648000.00
TARS balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 381143000.00
TARS balance_sheet (quarterly, 2025-06-30) — Cash Equivalents: 96648000.00
TARS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 1952000.00
TARS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -51704000.00
TARS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -29387000.00
TARS cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 12459000.00
TARS cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 1678000.00
TARS cash_flow (quarterly, 2025-06-30) — Change In Inventory: -1168000.00
TARS cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 102000.00
TARS cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -10165000.00
TARS cash_flow (quarterly, 2025-06-30) — Change In Payable: 12459000.00
TARS cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 14137000.00
TARS cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -23174000.00
TARS cash_flow (quarterly, 2025-06-30) — Change In Receivables: 3913000.00
TARS cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -16355000.00
TARS cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 4092000.00
TARS cash_flow (quarterly, 2025-06-30) — Changes In Cash: -79139000.00
TARS balance_sheet (quarterly, 2025-06-30) — Common Stock: 6000.00
TARS balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 332612000.00
TARS cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: -354000.00
TARS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 6237000.00
TARS balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 56729000.00
TARS balance_sheet (quarterly, 2025-06-30) — Current Assets: 474429000.00
TARS balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 317000.00
TARS balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 317000.00
TARS balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 90253000.00
TARS cash_flow (quarterly, 2025-06-30) — Depreciation: 213000.00
TARS cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 453000.00
TARS cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 453000.00
TARS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 42360452.00
TARS income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.48
TARS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -20340000.00
TARS income_statement (quarterly, 2025-06-30) — EBIT: -18246000.00
TARS income_statement (quarterly, 2025-06-30) — EBITDA: -17793000.00
TARS cash_flow (quarterly, 2025-06-30) — End Cash Position: 99211000.00
TARS cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 1952000.00
TARS balance_sheet (quarterly, 2025-06-30) — Finished Goods: 2291000.00
TARS cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -30388000.00
TARS balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 39000.00
TARS balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 7846000.00
TARS balance_sheet (quarterly, 2025-06-30) — Gross PPE: 5820000.00
TARS income_statement (quarterly, 2025-06-30) — Gross Profit: 96423000.00
TARS income_statement (quarterly, 2025-06-30) — Interest Expense: 2094000.00
TARS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 2094000.00
TARS income_statement (quarterly, 2025-06-30) — Interest Income: 4229000.00
TARS income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 4229000.00
TARS cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 2094000.00
TARS balance_sheet (quarterly, 2025-06-30) — Inventory: 3873000.00
TARS balance_sheet (quarterly, 2025-06-30) — Invested Capital: 404741000.00
TARS cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -51704000.00
TARS balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 3000000.00
TARS cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: -354000.00
TARS balance_sheet (quarterly, 2025-06-30) — Leases: 1160000.00
TARS balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 72129000.00
TARS balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 72129000.00
TARS balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 2752000.00
TARS cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -354000.00
TARS income_statement (quarterly, 2025-06-30) — Net Income: -20340000.00
TARS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -20340000.00
TARS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -20340000.00
TARS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -20340000.00
TARS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -20340000.00
TARS cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -20340000.00
TARS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -20340000.00
TARS income_statement (quarterly, 2025-06-30) — Net Interest Income: 1989000.00
TARS cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -50703000.00
TARS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 1989000.00
TARS balance_sheet (quarterly, 2025-06-30) — Net PPE: 3411000.00
TARS cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -1001000.00
TARS balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 324766000.00
TARS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -17793000.00
TARS income_statement (quarterly, 2025-06-30) — Normalized Income: -20340000.00
TARS cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -29387000.00
TARS income_statement (quarterly, 2025-06-30) — Operating Income: -22184000.00
TARS income_statement (quarterly, 2025-06-30) — Operating Revenue: 102660000.00
TARS balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 42210972.00
TARS balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 39000.00
TARS income_statement (quarterly, 2025-06-30) — Other Income Expense: -145000.00
TARS cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 305000.00
TARS balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 6308000.00
TARS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -145000.00
TARS balance_sheet (quarterly, 2025-06-30) — Other Payable: 5132000.00
TARS balance_sheet (quarterly, 2025-06-30) — Other Properties: 1908000.00
TARS balance_sheet (quarterly, 2025-06-30) — Other Receivables: 1906000.00
TARS balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 284495000.00
TARS balance_sheet (quarterly, 2025-06-30) — Payables: 33207000.00
TARS balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 89936000.00
TARS balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
TARS balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 29173000.00
TARS income_statement (quarterly, 2025-06-30) — Pretax Income: -20340000.00
TARS cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 2306000.00
TARS balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
TARS cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -129703000.00
TARS cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -1001000.00
TARS balance_sheet (quarterly, 2025-06-30) — Receivables: 60240000.00
TARS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 6237000.00
TARS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 453000.00
TARS income_statement (quarterly, 2025-06-30) — Research And Development: 15594000.00
TARS balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -405670000.00
TARS cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 79000000.00
TARS income_statement (quarterly, 2025-06-30) — Selling General And Administration: 103013000.00
TARS balance_sheet (quarterly, 2025-06-30) — Share Issued: 42210972.00
TARS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
TARS cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 8233000.00
TARS balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 332612000.00
TARS balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 324766000.00
TARS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
TARS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
TARS balance_sheet (quarterly, 2025-06-30) — Total Assets: 494994000.00
TARS balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 404741000.00
TARS balance_sheet (quarterly, 2025-06-30) — Total Debt: 72446000.00
TARS balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 332612000.00
TARS income_statement (quarterly, 2025-06-30) — Total Expenses: 124844000.00
TARS balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 162382000.00
TARS balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 20565000.00
TARS balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 72129000.00
TARS income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -22184000.00
TARS income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: 146000.00
TARS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
TARS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
TARS balance_sheet (quarterly, 2025-06-30) — Work In Process: 1582000.00
TARS balance_sheet (quarterly, 2025-06-30) — Working Capital: 384176000.00
TARS income_statement (quarterly, 2025-09-30) — +Operating Expense: 124917000.00
TARS income_statement (quarterly, 2025-09-30) — +Total Revenue: 118697000.00
TARS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 40642000.00
TARS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 72620000.00
TARS balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -2629000.00
TARS balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 753042000.00
TARS cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 240000.00
TARS cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 240000.00
TARS cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: -1534000.00
TARS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 42607717.00
TARS income_statement (quarterly, 2025-09-30) — Basic EPS: -0.30
TARS cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 99211000.00
TARS cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -1910000.00
TARS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 80000.00
TARS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 6000.00
TARS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 112724000.00
TARS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 401837000.00
TARS balance_sheet (quarterly, 2025-09-30) — Cash Equivalents: 112724000.00
TARS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 2562000.00
TARS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -4743000.00
TARS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 18257000.00
TARS cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 23842000.00
TARS cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 1940000.00
TARS cash_flow (quarterly, 2025-09-30) — Change In Inventory: 37000.00
TARS cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -373000.00
TARS cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 0.00
TARS cash_flow (quarterly, 2025-09-30) — Change In Payable: 23842000.00
TARS cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 25782000.00
TARS cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 7978000.00
TARS cash_flow (quarterly, 2025-09-30) — Change In Receivables: -14096000.00
TARS cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 19328000.00
TARS cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -14286000.00
TARS cash_flow (quarterly, 2025-09-30) — Changes In Cash: 16076000.00
TARS balance_sheet (quarterly, 2025-09-30) — Common Stock: 6000.00
TARS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 335082000.00
TARS cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
TARS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 8309000.00
TARS balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 69897000.00
TARS balance_sheet (quarterly, 2025-09-30) — Current Assets: 501704000.00
TARS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 80000.00
TARS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 80000.00
TARS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 117050000.00
TARS cash_flow (quarterly, 2025-09-30) — Depreciation: 220000.00
TARS cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 460000.00
TARS cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 460000.00
TARS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 42607717.00
TARS income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.30
TARS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -12585000.00
TARS income_statement (quarterly, 2025-09-30) — EBIT: -10469000.00
TARS income_statement (quarterly, 2025-09-30) — EBITDA: -10009000.00
TARS cash_flow (quarterly, 2025-09-30) — End Cash Position: 115287000.00
TARS cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 2562000.00
TARS balance_sheet (quarterly, 2025-09-30) — Finished Goods: 2835000.00
TARS cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 16347000.00
TARS balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 289000.00
TARS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 7606000.00
TARS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 18608000.00
TARS income_statement (quarterly, 2025-09-30) — Gross Profit: 110388000.00
TARS income_statement (quarterly, 2025-09-30) — Interest Expense: 2116000.00
TARS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 2116000.00
TARS income_statement (quarterly, 2025-09-30) — Interest Income: 4114000.00
TARS income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 4114000.00
TARS cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 2116000.00
TARS balance_sheet (quarterly, 2025-09-30) — Inventory: 3836000.00
TARS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 407363000.00
TARS cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -4743000.00
TARS balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 3000000.00
TARS cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
TARS cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 0.00
TARS balance_sheet (quarterly, 2025-09-30) — Leases: 3882000.00
TARS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 72281000.00
TARS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 72281000.00
TARS cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 0.00
TARS balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 2752000.00
TARS cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
TARS cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: -12000.00
TARS income_statement (quarterly, 2025-09-30) — Net Income: -12585000.00
TARS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -12585000.00
TARS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -12585000.00
TARS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -12585000.00
TARS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -12585000.00
TARS cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -12585000.00
TARS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -12585000.00
TARS income_statement (quarterly, 2025-09-30) — Net Interest Income: 1846000.00
TARS cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -2833000.00
TARS cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 0.00
TARS cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 0.00
TARS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 1846000.00
TARS balance_sheet (quarterly, 2025-09-30) — Net PPE: 15979000.00
TARS cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -1910000.00
TARS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 327476000.00
TARS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -10009000.00
TARS income_statement (quarterly, 2025-09-30) — Normalized Income: -12585000.00
TARS cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 18257000.00
TARS cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -12000.00
TARS income_statement (quarterly, 2025-09-30) — Operating Income: -14529000.00
TARS income_statement (quarterly, 2025-09-30) — Operating Revenue: 118697000.00
TARS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 42447882.00
TARS balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 289000.00
TARS income_statement (quarterly, 2025-09-30) — Other Income Expense: 98000.00
TARS cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 357000.00
TARS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 6272000.00
TARS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 10148000.00
TARS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 98000.00
TARS balance_sheet (quarterly, 2025-09-30) — Other Payable: 6431000.00
TARS balance_sheet (quarterly, 2025-09-30) — Other Properties: 11974000.00
TARS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 1716000.00
TARS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 289113000.00
TARS balance_sheet (quarterly, 2025-09-30) — Payables: 47073000.00
TARS balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 116970000.00
TARS balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
TARS balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 21695000.00
TARS income_statement (quarterly, 2025-09-30) — Pretax Income: -12585000.00
TARS cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 2562000.00
TARS balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
TARS cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -102333000.00
TARS cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -1910000.00
TARS balance_sheet (quarterly, 2025-09-30) — Receivables: 74336000.00
TARS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 8309000.00
TARS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 460000.00
TARS income_statement (quarterly, 2025-09-30) — Research And Development: 16284000.00
TARS balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -418255000.00
TARS cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 99500000.00
TARS income_statement (quarterly, 2025-09-30) — Selling General And Administration: 108633000.00
TARS balance_sheet (quarterly, 2025-09-30) — Share Issued: 42447882.00
TARS income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
TARS cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 12243000.00
TARS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 335082000.00
TARS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 327476000.00
TARS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
TARS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
TARS balance_sheet (quarterly, 2025-09-30) — Total Assets: 534561000.00
TARS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 407363000.00
TARS balance_sheet (quarterly, 2025-09-30) — Total Debt: 72361000.00
TARS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 335082000.00
TARS income_statement (quarterly, 2025-09-30) — Total Expenses: 133226000.00
TARS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 199479000.00
TARS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 32857000.00
TARS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 82429000.00
TARS income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -14529000.00
TARS income_statement (quarterly, 2025-09-30) — Total Other Finance Cost: 152000.00
TARS income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
TARS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
TARS balance_sheet (quarterly, 2025-09-30) — Work In Process: 1001000.00
TARS balance_sheet (quarterly, 2025-09-30) — Working Capital: 384654000.00
TARS income_statement (annual, 2025-12-31) — +Operating Expense: 491645000.00
TARS income_statement (quarterly, 2025-12-31) — +Operating Expense: 148717000.00
TARS income_statement (annual, 2025-12-31) — +Total Revenue: 451360000.00
TARS income_statement (quarterly, 2025-12-31) — +Total Revenue: 151668000.00
TARS balance_sheet (annual, 2025-12-31) — Accounts Payable: 16387000.00
TARS balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 16387000.00
TARS balance_sheet (annual, 2025-12-31) — Accounts Receivable: 85057000.00
TARS balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 85057000.00
TARS balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -2098000.00
TARS balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -2098000.00
TARS balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 769667000.00
TARS balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 769667000.00
TARS cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 961000.00
TARS cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 241000.00
TARS cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 961000.00
TARS cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 241000.00
TARS cash_flow (annual, 2025-12-31) — Amortization Of Securities: -5482000.00
TARS cash_flow (quarterly, 2025-12-31) — Amortization Of Securities: -925000.00
TARS income_statement (annual, 2025-12-31) — Basic Average Shares: 41784014.00
TARS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 42784688.00
TARS income_statement (annual, 2025-12-31) — Basic EPS: -1.59
TARS income_statement (quarterly, 2025-12-31) — Basic EPS: -0.20
TARS cash_flow (annual, 2025-12-31) — Beginning Cash Position: 97381000.00
TARS cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 115287000.00
TARS cash_flow (annual, 2025-12-31) — Capital Expenditure: -9859000.00
TARS cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -6358000.00
TARS balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 0.00
TARS balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 0.00
TARS balance_sheet (annual, 2025-12-31) — Capital Stock: 6000.00
TARS balance_sheet (quarterly, 2025-12-31) — Capital Stock: 6000.00
TARS balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 183641000.00
TARS balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 183641000.00
TARS balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 417268000.00
TARS balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 417268000.00
TARS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 143388000.00
TARS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 2312000.00
TARS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -42115000.00
TARS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 49274000.00
TARS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -12451000.00
TARS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 19330000.00
TARS cash_flow (annual, 2025-12-31) — Change In Account Payable: 6906000.00
TARS cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -30539000.00
TARS cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 1956000.00
TARS cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 4228000.00
TARS cash_flow (annual, 2025-12-31) — Change In Inventory: -1751000.00
TARS cash_flow (quarterly, 2025-12-31) — Change In Inventory: -536000.00
TARS cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -527000.00
TARS cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -381000.00
TARS cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 45389000.00
TARS cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 45389000.00
TARS cash_flow (annual, 2025-12-31) — Change In Payable: 6906000.00
TARS cash_flow (quarterly, 2025-12-31) — Change In Payable: -30539000.00
TARS cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 8862000.00
TARS cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -26311000.00
TARS cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 1716000.00
TARS cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 8187000.00
TARS cash_flow (annual, 2025-12-31) — Change In Receivables: -39051000.00
TARS cash_flow (quarterly, 2025-12-31) — Change In Receivables: -12773000.00
TARS cash_flow (annual, 2025-12-31) — Change In Working Capital: 14638000.00
TARS cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 13575000.00
TARS cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -38297000.00
TARS cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -12437000.00
TARS cash_flow (annual, 2025-12-31) — Changes In Cash: 88822000.00
TARS cash_flow (quarterly, 2025-12-31) — Changes In Cash: 70916000.00
TARS balance_sheet (annual, 2025-12-31) — Common Stock: 6000.00
TARS balance_sheet (quarterly, 2025-12-31) — Common Stock: 6000.00
TARS balance_sheet (annual, 2025-12-31) — Common Stock Equity: 343426000.00
TARS balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 343426000.00
TARS cash_flow (annual, 2025-12-31) — Common Stock Issuance: 134771000.00
TARS cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
TARS income_statement (annual, 2025-12-31) — Cost Of Revenue: 30684000.00
TARS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 10927000.00
TARS balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 86218000.00
TARS balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 86218000.00
TARS balance_sheet (annual, 2025-12-31) — Current Assets: 522782000.00
TARS balance_sheet (quarterly, 2025-12-31) — Current Assets: 522782000.00
TARS balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 0.00
TARS balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 0.00
TARS balance_sheet (annual, 2025-12-31) — Current Liabilities: 135695000.00
TARS balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 135695000.00
TARS cash_flow (annual, 2025-12-31) — Depreciation: 855000.00
TARS cash_flow (quarterly, 2025-12-31) — Depreciation: 202000.00
TARS cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 1816000.00
TARS cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 443000.00
TARS cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 1816000.00
TARS cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 443000.00
TARS income_statement (annual, 2025-12-31) — Diluted Average Shares: 41784014.00
TARS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 42784688.00
TARS income_statement (annual, 2025-12-31) — Diluted EPS: -1.59
TARS income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.20
TARS income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -66418000.00
TARS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -8373000.00
TARS income_statement (annual, 2025-12-31) — EBIT: -56017000.00
TARS income_statement (quarterly, 2025-12-31) — EBIT: -4256000.00
TARS income_statement (annual, 2025-12-31) — EBITDA: -54201000.00
TARS income_statement (quarterly, 2025-12-31) — EBITDA: -3813000.00
TARS cash_flow (annual, 2025-12-31) — End Cash Position: 186203000.00
TARS cash_flow (quarterly, 2025-12-31) — End Cash Position: 186203000.00
TARS cash_flow (annual, 2025-12-31) — Financing Cash Flow: 143388000.00
TARS cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 2312000.00
TARS balance_sheet (annual, 2025-12-31) — Finished Goods: 2962000.00
TARS balance_sheet (quarterly, 2025-12-31) — Finished Goods: 2962000.00
TARS cash_flow (annual, 2025-12-31) — Free Cash Flow: -22310000.00
TARS cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 12972000.00
TARS balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 381000.00
TARS balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 381000.00
TARS balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 7366000.00
TARS balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 7366000.00
TARS balance_sheet (annual, 2025-12-31) — Gross PPE: 23843000.00
TARS balance_sheet (quarterly, 2025-12-31) — Gross PPE: 23843000.00
TARS income_statement (annual, 2025-12-31) — Gross Profit: 420676000.00
TARS income_statement (quarterly, 2025-12-31) — Gross Profit: 140741000.00
TARS balance_sheet (annual, 2025-12-31) — Income Tax Payable: 1811000.00
TARS balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 1811000.00
TARS income_statement (annual, 2025-12-31) — Interest Expense: 8342000.00
TARS income_statement (quarterly, 2025-12-31) — Interest Expense: 2058000.00
TARS income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 8342000.00
TARS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 2058000.00
TARS income_statement (annual, 2025-12-31) — Interest Income: 15747000.00
TARS income_statement (quarterly, 2025-12-31) — Interest Income: 3950000.00
TARS income_statement (annual, 2025-12-31) — Interest Income Non Operating: 15747000.00
TARS income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 3950000.00
TARS cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 8342000.00
TARS cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 2058000.00
TARS balance_sheet (annual, 2025-12-31) — Inventory: 4372000.00
TARS balance_sheet (quarterly, 2025-12-31) — Inventory: 4372000.00
TARS balance_sheet (annual, 2025-12-31) — Invested Capital: 415864000.00
TARS balance_sheet (quarterly, 2025-12-31) — Invested Capital: 415864000.00
TARS cash_flow (annual, 2025-12-31) — Investing Cash Flow: -42115000.00
TARS cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 49274000.00
TARS balance_sheet (annual, 2025-12-31) — Investments And Advances: 3870000.00
TARS balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 3870000.00
TARS cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 134771000.00
TARS cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
TARS cash_flow (annual, 2025-12-31) — Issuance Of Debt: 0.00
TARS cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 0.00
TARS balance_sheet (annual, 2025-12-31) — Leases: 9925000.00
TARS balance_sheet (quarterly, 2025-12-31) — Leases: 9925000.00
TARS balance_sheet (annual, 2025-12-31) — Long Term Debt: 72438000.00
TARS balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 72438000.00
TARS balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 72438000.00
TARS balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 72438000.00
TARS cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 0.00
TARS cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 0.00
TARS balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 2265000.00
TARS balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 2265000.00
TARS cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 134771000.00
TARS cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
TARS income_statement (annual, 2025-12-31) — Net Income: -66418000.00
TARS income_statement (quarterly, 2025-12-31) — Net Income: -8373000.00
TARS income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -66418000.00
TARS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -8373000.00
TARS income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -66418000.00
TARS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -8373000.00
TARS income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -66418000.00
TARS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -8373000.00
TARS income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -66418000.00
TARS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -8373000.00
TARS cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -66418000.00
TARS cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -8373000.00
TARS income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -66418000.00
TARS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -8373000.00
TARS cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: 0.00
TARS income_statement (annual, 2025-12-31) — Net Interest Income: 6812000.00
TARS income_statement (quarterly, 2025-12-31) — Net Interest Income: 1736000.00
TARS cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -32256000.00
TARS cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 55632000.00
TARS cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 0.00
TARS cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 0.00
TARS cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 0.00
TARS cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 0.00
TARS income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 6812000.00
TARS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 1736000.00
TARS balance_sheet (annual, 2025-12-31) — Net PPE: 21745000.00
TARS balance_sheet (quarterly, 2025-12-31) — Net PPE: 21745000.00
TARS cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -9859000.00
TARS cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -6358000.00
TARS balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 336060000.00
TARS balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 336060000.00
TARS income_statement (annual, 2025-12-31) — Normalized EBITDA: -54201000.00
TARS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -3813000.00
TARS income_statement (annual, 2025-12-31) — Normalized Income: -66418000.00
TARS income_statement (quarterly, 2025-12-31) — Normalized Income: -8373000.00
TARS cash_flow (annual, 2025-12-31) — Operating Cash Flow: -12451000.00
TARS cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 19330000.00
TARS income_statement (annual, 2025-12-31) — Operating Income: -70969000.00
TARS income_statement (quarterly, 2025-12-31) — Operating Income: -7976000.00
TARS income_statement (annual, 2025-12-31) — Operating Revenue: 451360000.00
TARS income_statement (quarterly, 2025-12-31) — Operating Revenue: 151668000.00
TARS balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 42553931.00
TARS balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 42553931.00
TARS balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 22179000.00
TARS balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 22179000.00
TARS balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 381000.00
TARS balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 381000.00
TARS income_statement (annual, 2025-12-31) — Other Income Expense: -202000.00
TARS income_statement (quarterly, 2025-12-31) — Other Income Expense: -74000.00
TARS cash_flow (annual, 2025-12-31) — Other Non Cash Items: 1275000.00
TARS cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 310000.00
TARS balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 6395000.00
TARS balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 6395000.00
TARS balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 10599000.00
TARS balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 10599000.00
TARS income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -202000.00
TARS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -74000.00
TARS balance_sheet (annual, 2025-12-31) — Other Payable: 9100000.00
TARS balance_sheet (quarterly, 2025-12-31) — Other Payable: 9100000.00
TARS balance_sheet (annual, 2025-12-31) — Other Properties: 11653000.00
TARS balance_sheet (quarterly, 2025-12-31) — Other Properties: 11653000.00
TARS balance_sheet (annual, 2025-12-31) — Other Receivables: 2052000.00
TARS balance_sheet (quarterly, 2025-12-31) — Other Receivables: 2052000.00
TARS balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 233627000.00
TARS balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 233627000.00
TARS balance_sheet (annual, 2025-12-31) — Payables: 27298000.00
TARS balance_sheet (quarterly, 2025-12-31) — Payables: 27298000.00
TARS balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 113516000.00
TARS balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 113516000.00
TARS balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
TARS balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
TARS balance_sheet (annual, 2025-12-31) — Prepaid Assets: 13473000.00
TARS balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 13473000.00
TARS income_statement (annual, 2025-12-31) — Pretax Income: -64359000.00
TARS income_statement (quarterly, 2025-12-31) — Pretax Income: -6314000.00
TARS cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 8617000.00
TARS cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 2312000.00
TARS balance_sheet (annual, 2025-12-31) — Properties: 0.00
TARS balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
TARS cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: 0.00
TARS cash_flow (annual, 2025-12-31) — Purchase Of Investment: -394056000.00
TARS cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -36450000.00
TARS cash_flow (annual, 2025-12-31) — Purchase Of PPE: -9859000.00
TARS cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -6358000.00
TARS balance_sheet (annual, 2025-12-31) — Receivables: 87109000.00
TARS balance_sheet (quarterly, 2025-12-31) — Receivables: 87109000.00
TARS income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 30684000.00
TARS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 10927000.00
TARS income_statement (annual, 2025-12-31) — Reconciled Depreciation: 1816000.00
TARS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 443000.00
TARS income_statement (annual, 2025-12-31) — Research And Development: 64322000.00
TARS income_statement (quarterly, 2025-12-31) — Research And Development: 18035000.00
TARS balance_sheet (annual, 2025-12-31) — Restricted Cash: 560000.00
TARS balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 560000.00
TARS balance_sheet (annual, 2025-12-31) — Retained Earnings: -426628000.00
TARS balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -426628000.00
TARS cash_flow (annual, 2025-12-31) — Sale Of Investment: 361800000.00
TARS cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 92082000.00
TARS income_statement (annual, 2025-12-31) — Selling General And Administration: 427323000.00
TARS income_statement (quarterly, 2025-12-31) — Selling General And Administration: 130682000.00
TARS balance_sheet (annual, 2025-12-31) — Share Issued: 42553931.00
TARS balance_sheet (quarterly, 2025-12-31) — Share Issued: 42553931.00
TARS income_statement (annual, 2025-12-31) — Special Income Charges: 0.00
TARS income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
TARS cash_flow (annual, 2025-12-31) — Stock Based Compensation: 41720000.00
TARS cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 14314000.00
TARS balance_sheet (annual, 2025-12-31) — Stockholders Equity: 343426000.00
TARS balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 343426000.00
TARS balance_sheet (annual, 2025-12-31) — Tangible Book Value: 336060000.00
TARS balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 336060000.00
TARS income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
TARS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
TARS income_statement (annual, 2025-12-31) — Tax Provision: 2059000.00
TARS income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
TARS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
TARS balance_sheet (annual, 2025-12-31) — Total Assets: 562158000.00
TARS balance_sheet (quarterly, 2025-12-31) — Total Assets: 562158000.00
TARS balance_sheet (annual, 2025-12-31) — Total Capitalization: 415864000.00
TARS balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 415864000.00
TARS balance_sheet (annual, 2025-12-31) — Total Debt: 72438000.00
TARS balance_sheet (quarterly, 2025-12-31) — Total Debt: 72438000.00
TARS balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 343426000.00
TARS balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 343426000.00
TARS income_statement (annual, 2025-12-31) — Total Expenses: 522329000.00
TARS income_statement (quarterly, 2025-12-31) — Total Expenses: 159644000.00
TARS balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 218732000.00
TARS balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 218732000.00
TARS balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 39376000.00
TARS balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 39376000.00
TARS balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 83037000.00
TARS balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 83037000.00
TARS income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -70969000.00
TARS income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -7976000.00
TARS income_statement (annual, 2025-12-31) — Total Other Finance Cost: 593000.00
TARS income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: 156000.00
TARS balance_sheet (annual, 2025-12-31) — Total Tax Payable: 1811000.00
TARS balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 1811000.00
TARS income_statement (annual, 2025-12-31) — Total Unusual Items: 0.00
TARS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00